Cogent Biosciences, Inc. (COGT)
39.76
-0.48
(-1.19%)
USD |
NASDAQ |
Jul 24, 16:00
39.74
-0.02
(-0.05%)
After-Hours: 20:00
Cogent Biosciences Price to Book Value : 12.51 for July 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 24, 2026 | 12.51 |
| July 23, 2026 | 12.66 |
| July 22, 2026 | 12.44 |
| July 21, 2026 | 12.47 |
| July 20, 2026 | 12.05 |
| July 17, 2026 | 12.30 |
| July 16, 2026 | 11.94 |
| July 15, 2026 | 12.36 |
| July 14, 2026 | 12.12 |
| July 13, 2026 | 11.79 |
| July 10, 2026 | 12.23 |
| July 09, 2026 | 12.75 |
| July 08, 2026 | 12.58 |
| July 07, 2026 | 12.59 |
| July 06, 2026 | 12.41 |
| July 02, 2026 | 12.17 |
| July 01, 2026 | 12.11 |
| June 30, 2026 | 12.18 |
| June 29, 2026 | 12.19 |
| June 26, 2026 | 11.99 |
| June 25, 2026 | 11.96 |
| June 24, 2026 | 11.81 |
| June 23, 2026 | 11.42 |
| June 22, 2026 | 11.28 |
| June 18, 2026 | 10.87 |
| Date | Value |
|---|---|
| June 17, 2026 | 10.59 |
| June 16, 2026 | 10.40 |
| June 15, 2026 | 10.44 |
| June 12, 2026 | 10.41 |
| June 11, 2026 | 10.26 |
| June 10, 2026 | 9.873 |
| June 09, 2026 | 10.06 |
| June 08, 2026 | 9.803 |
| June 05, 2026 | 9.759 |
| June 04, 2026 | 10.32 |
| June 03, 2026 | 10.15 |
| June 02, 2026 | 10.31 |
| June 01, 2026 | 10.95 |
| May 29, 2026 | 11.00 |
| May 28, 2026 | 11.13 |
| May 27, 2026 | 10.86 |
| May 26, 2026 | 10.68 |
| May 22, 2026 | 10.28 |
| May 21, 2026 | 10.25 |
| May 20, 2026 | 10.36 |
| May 19, 2026 | 9.832 |
| May 18, 2026 | 9.866 |
| May 15, 2026 | 10.28 |
| May 14, 2026 | 10.76 |
| May 13, 2026 | 10.79 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vir Biotechnology, Inc. | 1.724 |
| Revolution Medicines, Inc. | 25.25 |
| ImmunityBio, Inc. | -- |
| Erasca, Inc. | 15.09 |
| Tyra Biosciences, Inc. | 4.700 |
Price to Book Value Related Metrics
| PEG Ratio | -3.464 |
| Price | 39.76 |
| Earnings Yield | -6.35% |
| Market Cap | 6.792B |
| PEGY Ratio | -3.464 |